Oral doxophylline in patients with chronic obstructive pulmonary disease

International Journal of Clinical Pharmacology and Therapeutics

Volumn 35, Issue 3, 1997, Pages 107-111

  Villani, F ^a   De Maria, P ^a   Ronchi, E ^a   Galimberti, M ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Chronic obstructive pulmonary disease; Doxophylline

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; DOXOFYLLINE; SALBUTAMOL; THEOPHYLLINE DERIVATIVE;

ADULT; AGED; ANXIETY; ARTERIAL BLOOD; ARTICLE; BLOOD GAS ANALYSIS; BLOOD OXYGEN TENSION; BRONCHODILATING ACTIVITY; CARBON DIOXIDE BLOOD LEVEL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; DRUG BLOOD LEVEL; DYSPEPSIA; FEMALE; FORCED EXPIRATORY VOLUME; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PEAK EXPIRATORY FLOW; RESIDUAL VOLUME; SPIROMETRY; VITAL CAPACITY;

ADMINISTRATION, ORAL; ADRENERGIC BETA-AGONISTS; ADULT; AGED; ALBUTEROL; ANTITUSSIVE AGENTS; BLOOD GAS ANALYSIS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; FORCED EXPIRATORY FLOW RATES; HUMANS; LUNG DISEASES, OBSTRUCTIVE; MALE; MIDDLE AGED; RESPIRATORY FUNCTION TESTS; SPIROMETRY; THEOPHYLLINE; TREATMENT OUTCOME;

EID: 0030932308     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Aiolfi S, Gandola L, Patrini G, Ghio L, Scartabellati A, Mauri F, Confalonieri M, Parigi P, Trogui M 1994 Efficacia e tollerabilità della doxofillina endovenosa nel trattamento delle sindromi respiratorie acute con componente broncostruttiva. Med Toracica 16: 165-168
2. Aubier M, Murciano P, Viires N, Lecocguic Y, Palacios S, Pariente R 1983 Increased ventilation caused by improved diaphragmatic efficiency during aminophylline infusion. Am Rev Respir Dis 127: 148-155
3. Badini C, Masera F, Franzone JS 1982 Dosaggio del 2(7′-teofillinmetil)1,3-diossolano mediante HPLC. Farmaco (Prat) 37: 320-324
4. Bologna E, Laganà A, Terracino D, Bolignani P, Biffignardi P 1990 Oral and intravenous pharmacokinetics profiles of doxophylline in patients with chronic bronchitis. J Int Med Res 18: 282-288
5. Bucca C, Rolla G, Fonzo D, Franzone JS, Di Carlo R 1982 Acute clinical-pharmacologic findings in obstructive pneumopathy following 2(7′-theophyllinemethyl)1,3-dioxolane (doxophylline). Int J Clin Pharmacol Res 2: 101-103
6. Chrystyn H, Mulley BA, Peake MD 1988 Dose response relation to oral theophylline in severe chronic obstructive airway disease. Br Med J 297: 1506-1510
7. Cipri A, Pozzar F, Dini FL 1992 Alterazioni del ritmo cardiaco in pazienti con broncopneumopatia cronica ostruttiva: effetto di differenti farmaci metilxantinici. Minerva Cardioangiol 11: 37-42
8. Cirillo R, Barone D, Franzone JS 1988 Doxophylline and theophylline are xanthines with partly different mechanisms in animals. Drug Exp Med Res 16: 264-270
9. Cogo R, Dini FL, DeLuca P, Ramponi A 1991 Effetti della associazione doxofillina-nifedipina nel trattamento dell'ipertensione polmonare precapillare in pazienti BPCO. Ras Pat App Respir 4 (Suppl 1): 130-142
10. Dini FL 1991 Chronotropic and arrhythmogenetic effects of two methylxanthine bronchodilators: doxophylline and aminophylline, evaluated by Holter monitoring. Comparison with experimental in vitro and in vivo results. Curr Ther Res 49: 978-985
11. Dini FL 1995 Orally administered methylxanthines improve gas exchange and exercise tolerance in patients with chronic hypoxaemic heart failure (Abstr). Eur Heart J 16 (Suppl 1): 151
12. Dolcetti A, Osella D, Carnucccio C, Maccario G, Moschini MT 1988 Studio degli effetti dell'impiego endovenoso della doxofillina, un nuovo derivato metilxantinico, nel trattamento di pazienti affetti da broncopneumopatia cronica ostruttiva. Minerva Pneum 27: 211-215
13. Dolcetti A, Osella D, De Filippi G, Carnuccio G, Grossi E 1988 Comparison of intravenously administered doxophylline and placebo for the treatment of severe acute airway obstruction. J Int Med Res 16: 264-269
14. Eldridge PL, Millhorn DE, Waldrop TG, Kiley JP 1983 Mechanism of respiratory effects of methylxanthine. Respir Physiol 53: 239-261
15. Franzone JS, Reboani C, Fonzo D, Di Carlo R 1981 Pharmacological researches on 2-(7′-theophyllinemethyl)1,3-dioxolane. Farmaco Sci 36: 201-219
16. Grossi C, Biffignandi P, Franzone JS 1988 La doxofillina: profila del farmaco e rassegna degli studi clinici. Eur Rev Med Pharmacol Sci 10: 1-16
17. Iodice F, De Michele F, Piscione F, Golino P, Focaccio A, Scotto-D'Abusco R, Sena A, Chiariello M 1989 Effetti emodinamici della somministrazione acuta di doxofillina in soggetti normali e in pazienti BPCO. Ras Pat App Respir 4: 91-96
18. Matthay RA, Berger HJ, Loke J, Gottschalk A, Zaret BL 1978 Effects of aminophylline upon right and left ventricular performance in chronic obstructive pulmonary disease: noninvasive assessment by radionuclide angiocardiography. Am J Med 65: 903-910
19. Murciano P, Aubier M, Lecocguic Y, Pariente R 1984 Effect of theophylline on diaphragmatic strength and fatigue in patients with chronic obstructive pulmonary disease. N Engl J Med 311: 349-353
20. Nosenza M, Piana GC, Cocozza P, Serra M, Faravelli B 1987 Efficacia e tollerabilità di un nuovo farmaco broncodilatatore: la doxofillina (dati preliminari). Ras Pat App Respir 3: 91-94
21. Paterson JW, Worlcock AJ, Shenfield GM 1979 State of the Art. Bronchodilator drugs. Am Rev Respir Dis 120: 1149-1188
22. Poggí R, Brandolese R, Bernasconi M, Manzin E, Rossi A 1989 Doxophylline and respiratory mechanism. Short-time effects in mechanically ventilated patients with airflow obstruction and respiratory failure. Chest 96: 772-778
23. Rogers TK, Bardsley PA 1991 Drug therapy of chronic bronchitis and emphysema. Eur Respir Rev 6: 525-535
24. Rossi GL, Lodigiani L, Dellabianca A, Maccaccini P, Vinci G, Bertoletti R, Moscato G 1992 Effetto della doxofillina, a confronto con raminofillina, sul calibro bronchiale e sulle risposte bronchiali specifiche a Dermatophagoides pteronyssinus in soggetti asmatici. Med Toracica 14: 75-79
25. Stavric B 1988 Methylxanthines: toxicity to humans. 1: Theophylline. J Chem Toxicol 26: 541-565
26. Taglioro F, Dorizzi R, Frigerio A, Marigo M 1990 Non-extraction HPLC method for simultaneous measurement of dyphylline and doxophylline in serum. Clin Chem 36: 113-115
27. Villani F, Galimberti M, Pizzini L, Formelli F 1991 Doxophylline, a new theophylline derivative, in chronic obstructive bronchopneumopathy. Eur Respir J 14 (Suppl): 5865
28. Waterhouse JC, Protehard SM, Howard P 1993 Hyperinflation trapped gas and theophylline in chronic obstructive pulmonary disease. Monaldi Arch Chest Dis 48: 126-129